Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018)
{{output}}
Introduction: Dipeptidyl peptidase 4 (DPP-4) belongs to the family of serine proteases and is involved in the degradation of GLP-1 and GIP hormones, which enhance the production and release of insulin. Targeting DPP-4 inhibitors ... ...
